Enhanced Antitumor Potency of Polyethylene Glycolylated Tumor Necrosis Factor-α: A Novel Polymer-Conjugation Technique with a Reversible Amino-Protective Reagent
- 1 July 1999
- journal article
- Published by Elsevier in The Journal of Pharmacology and Experimental Therapeutics
- Vol. 290 (1) , 368-372
- https://doi.org/10.1016/s0022-3565(24)34909-2
Abstract
No abstract availableThis publication has 35 references indexed in Scilit:
- Amino Acids and Peptides: XXXIII. A Bifunctional Poly(ethylene Glycol) Hybrid of Laminin-Related PeptidesBiochemical and Biophysical Research Communications, 1998
- Molecular design of hybrid tumour necrosis factor alpha with polyethylene glycol increases its anti-tumour potencyBritish Journal of Cancer, 1995
- TNF and other cytokines in the metabolism of septic shock and cachexiaClinical Nutrition, 1992
- Localization of the active site of human tumour necrosis factor (hTNF) by mutational analysis.The EMBO Journal, 1991
- Continuous infusion of tumor necrosis factor: Mechanisms of toxicity in the ratJournal of Surgical Research, 1988
- Human cytokines, tumor necrosis factor, and interferons: Gene cloning, animal studies, and clinical trialsJournal of Cellular Biochemistry, 1988
- A Progress Report on the Treatment of 157 Patients with Advanced Cancer Using Lymphokine-Activated Killer Cells and Interleukin-2 or High-Dose Interleukin-2 AloneNew England Journal of Medicine, 1987
- Phase I study of recombinant human tumor necrosis factorCancer Chemotherapy and Pharmacology, 1987
- A fluorometric assay of the degree of modification of protein primary amines with polyethylene glycolAnalytical Biochemistry, 1986
- Effect of tumour necrosis factor on cultured human melanoma cellsNature, 1975